
Uviquity is transforming disinfection with its proprietary solid-state technology that generates human-safe, pathogen-eliminating far-UVC light. This innovative semiconductor chip allows for the disinfection of air, food, and water at scale, addressing the global challenge of airborne infections, food poisoning, and contaminated drinking water. With a focus on safety and efficacy, Uviquity aims to create disease-free environments without the use of chemicals, making it a leader in the disinfection technology market.

Uviquity is transforming disinfection with its proprietary solid-state technology that generates human-safe, pathogen-eliminating far-UVC light. This innovative semiconductor chip allows for the disinfection of air, food, and water at scale, addressing the global challenge of airborne infections, food poisoning, and contaminated drinking water. With a focus on safety and efficacy, Uviquity aims to create disease-free environments without the use of chemicals, making it a leader in the disinfection technology market.
Founded / HQ: 2022; Raleigh, North Carolina (U.S.)
Product: Solid-state far-UVC "light engine": a proprietary photonics semiconductor chip that generates human-safe, pathogen‑eliminating far‑UVC light
Applications: Disinfection of air, food, and water at scale
Funding (seed): At least USD 13,274,620 across two disclosed seed rounds (2024-09-05 and 2025-05-07)
Lead / notable investors: Emerald Development Managers (lead); MANN+HUMMEL, AgFunder, CIG Spectrum Capital
Pathogen elimination and disinfection (airborne infections, food contamination, contaminated water) through photonic far‑UVC technology.
2022
DeepTech
USD 6,674,620
Investors listed: Emerald Development Managers (lead), MANN+HUMMEL, CIG Spectrum Capital, AgFunder
USD 6,600,000
Investors listed: Emerald Development Managers (lead), MANN+HUMMEL, AgFunder
“Seed rounds include Emerald Development Managers as lead and feature both venture (AgFunder, CIG Spectrum Capital) and strategic/industry investor participation (MANN+HUMMEL).”